↓ Skip to main content

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Overview of attention for article published in CA: A Cancer Journal for Clinicians , March 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news
2 news outlets
twitter
91 X users

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
51 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer
Published in
CA: A Cancer Journal for Clinicians , March 2023
DOI 10.3322/caac.21777
Pubmed ID
Authors

Laura A Huppert, Ozge Gumusay, Dame Idossa, Hope S Rugo

X Demographics

X Demographics

The data shown below were collected from the profiles of 91 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 51 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 10%
Other 4 8%
Student > Bachelor 4 8%
Researcher 3 6%
Unspecified 2 4%
Other 5 10%
Unknown 28 55%
Readers by discipline Count As %
Medicine and Dentistry 11 22%
Biochemistry, Genetics and Molecular Biology 4 8%
Unspecified 2 4%
Engineering 2 4%
Immunology and Microbiology 1 2%
Other 2 4%
Unknown 29 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 69. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 April 2024.
All research outputs
#629,322
of 25,744,802 outputs
Outputs from CA: A Cancer Journal for Clinicians
#158
of 1,040 outputs
Outputs of similar age
#14,092
of 424,431 outputs
Outputs of similar age from CA: A Cancer Journal for Clinicians
#3
of 12 outputs
Altmetric has tracked 25,744,802 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,040 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 78.0. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 424,431 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.